Literature DB >> 11247901

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors.

R Issa1, E Williams, N Trim, T Kendall, M J Arthur, J Reichen, R C Benyon, J P Iredale.   

Abstract

BACKGROUND: Activated hepatic stellate cells (HSC) are central to the pathogenesis of liver fibrosis, both as a source of fibrillar collagens that characterise fibrosis and matrix degrading metalloproteinases and their tissue inhibitors, the TIMPs. AIMS: To test the hypothesis that HSC apoptosis is critical to recovery from biliary fibrosis and that soluble growth factors may regulate HSC survival and apoptosis.
METHODS: Rats (n=15) were subjected to bile duct ligation for 21 days, after which biliodigestive anastomosis was undertaken (n=13). Livers were harvested at fixed time points of recovery for periods of up to 42 days. Numbers of activated HSCs were quantified after alpha smooth muscle actin staining and HSC apoptosis was detected by terminal UDP-nick end labelling (TUNEL) staining and quantified at each time point. HSC apoptosis was quantified in vitro in the presence or absence of insulin-like growth factor (IGF)-1, IGF-2, platelet derived growth factor (PDGF), and transforming growth factor beta1 (TGF-beta1).
RESULTS: Following biliodigestive anastomosis after 21 days of bile duct ligation, rat liver demonstrated a progressive resolution of biliary fibrosis over 42 days, associated with a fivefold decrease in activated HSC determined by alpha smooth muscle actin staining. TUNEL staining indicated that loss of activated HSC resulted from an increase in the rate of apoptosis during the first two days post biliodigestive anastomosis. Serum deprivation and culture in the presence of 50 microM cycloheximide was associated with an increase in HSC apoptosis which was significantly inhibited by addition of 10 ng/ml and 100 ng/ml IGF-1, respectively (0.05>p, n=5). In contrast, 1 and 10 ng/ml of TGF-beta1 caused a significant increase in HSC apoptosis compared with serum free controls (p<0.05, n=4). PDGF and IGF-2 were neutral with respect to their effect on HSC apoptosis.
CONCLUSION: HSC apoptosis plays a critical role in the spontaneous recovery from biliary fibrosis. Both survival and apoptosis of HSC are regulated by growth factors expressed during fibrotic liver injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247901      PMCID: PMC1728234          DOI: 10.1136/gut.48.4.548

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  The interaction of Bcl-2 and Bax regulates apoptosis in biliary epithelial cells of rats with obstructive jaundice.

Authors:  B J Stähelin; U Marti; H Zimmermann; J Reichen
Journal:  Virchows Arch       Date:  1999-04       Impact factor: 4.064

Review 2.  Hepatic fibrosis.

Authors:  M Rojkind; M A Dunn
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

3.  False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate.

Authors:  B J Stähelin; U Marti; M Solioz; H Zimmermann; J Reichen
Journal:  Mol Pathol       Date:  1998-08

4.  Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand.

Authors:  W Gong; A Pecci; S Roth; B Lahme; M Beato; A M Gressner
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

5.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.

Authors:  M J Arthur; S L Friedman; F J Roll; D M Bissell
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.

Authors:  S L Friedman; F J Roll; J Boyles; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet-derived growth factor.

Authors:  M Pinzani; H E Abboud; D C Aron
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

8.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

Authors:  M Pinzani; L Gesualdo; G M Sabbah; H E Abboud
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

9.  Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling.

Authors:  G Romano; M Prisco; T Zanocco-Marani; F Peruzzi; B Valentinis; R Baserga
Journal:  J Cell Biochem       Date:  1999-02-01       Impact factor: 4.429

10.  Insulin-like growth factor-I-mediated survival from anoikis: role of cell aggregation and focal adhesion kinase.

Authors:  B Valentinis; K Reiss; R Baserga
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

View more
  89 in total

Review 1.  Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis.

Authors:  Eugene Kissin; Joseph H Korn
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation.

Authors:  Xiao-Lan Zhang; Li Liu; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 3.  Liver fibrosis: a bidirectional model of fibrogenesis and resolution.

Authors:  P Ramachandran; J P Iredale
Journal:  QJM       Date:  2012-05-29

Review 4.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

Review 5.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

Review 6.  Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies.

Authors:  Jing-Ting Li; Zhang-Xiu Liao; Jie Ping; Dan Xu; Hui Wang
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

Review 7.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

8.  Effects of Shenqi Neijin powder on activation and apoptosis of hepatic stellate cells in rats with hepatic fibrosis.

Authors:  Hongdong Xie; Wei Hou; Yide Yang; Ying Yu; Fengling Wang; Juanjuan Mao
Journal:  Int J Clin Exp Med       Date:  2015-01-09

9.  Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody.

Authors:  Xiao-Jing Liu; Li Yang; Hong-Bin Wu; Ou Qiang; Ming-Hui Huang; Ying-Ping Wang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.

Authors:  Yury Popov; Deanna Y Sverdlov; K Ramakrishnan Bhaskar; Anisha K Sharma; Gunda Millonig; Eleonora Patsenker; Stephan Krahenbuhl; Lukas Krahenbuhl; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-07       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.